Frazier Financial Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3K Sell
406
-352
-46% -$19.1K 0.01% 329
2026
Q1
$47.6K Buy
758
+273
+56% +$21.8K 0.03% 194
2025
Q4
$46.2K Hold
485
0.03% 170
2025
Q3
$47.4K Sell
485
-56
-10% -$5.8K 0.03% 159
2025
Q2
$58.1K Buy
541
+56
+12% +$5.67K 0.04% 138
2025
Q1
$48.9K Hold
485
0.04% 139
2024
Q4
$43.5K Sell
485
-66
-12% -$5.81K 0.03% 147
2024
Q3
$46.2K Sell
551
-79
-13% -$6.23K 0.04% 144
2024
Q2
$48.5K Buy
630
+60
+11% +$4.39K 0.04% 156
2024
Q1
$39K Buy
570
+22
+4% +$1.42K 0.03% 176
2023
Q4
$31.7K Buy
+548
New +$29.3K 0.03% 177

Other funds holding BSX

Frazier Financial Advisors's BSX Position: Q2 2026 in Review

Frazier Financial Advisors reduced its Boston Scientific (BSX) stake by 46% in Q2 2026, selling an estimated $19.1K and leaving 406 shares worth $17.3K. The position accounts for 0.01% of the portfolio, ranked #329.

Frazier Financial Advisors first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $58.1K in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Frazier Financial Advisors held 406 shares of Boston Scientific worth $17.3K as of Q2 2026.
  • Frazier Financial Advisors sold 352 Boston Scientific shares in Q2 2026, an estimated $19.1K.
  • Boston Scientific made up 0.01% of Frazier Financial Advisors's portfolio in Q2 2026, its #329 holding.
  • Frazier Financial Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Frazier Financial Advisors's Boston Scientific position peaked at $58.1K in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.